Mazdutide , cagrilintide , and orforglipron (an oral GLP-1 agonist) represent additional next-generation options that could offer different benefit-risk profiles for endometriosis patients
Ongoing Care Regular follow-ups with biomarker tracking, clinical assessments, and protocol optimization to maximize your longevity outcomes
EXION is a strong option for people noticing early signs of aging, mild skin laxity, fine lines, uneven texture, or dullness, and who prefer a non-surgical approach with little downtime
Dose upon waking, regardless of clock time
Dosage (volume) use: There is no fixed dose of bacteriostatic water in the usual sense
Most of the research behind BPC-157 comes from preclinical studies focused on tissue repair, gut integrity, and inflammation, not on body fat reduction, appetite suppression, or metabolic rate